TEVA PHARMACEUTICAL INDUSTRIES LIMITED Impairment of Intangible Assets, Finite-lived
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Impairment of Intangible Assets, Finite-lived of $361.00 million for the 12-month period ending 2015-12-31, per its 20-F filed 2016-02-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2016-02-11
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED impairment of intangible assets, finite-lived for the quarter ending 2014-12-31 was $198.00M, a 14.45% increase year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED impairment of intangible assets, finite-lived for the quarter ending 2013-12-31 was $173.00M.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 9 month | Impairment of Intangible Assets, Finite-lived 12 month | Impairment of Intangible Assets, Finite-lived 12 month as first filed |
|---|---|---|---|---|
| 2015-12-31 | $361.00M 20-F · filed 2016-02-11 | |||
| 2014-12-31 | $198.00M derived: 20-F 12 month − 6-K 9 month · filed 2016-02-11 | $227.00M 20-F · filed 2016-02-11 | ||
| 2014-09-30 | $29.00M 6-K · filed 2014-10-30 | |||
| 2013-12-31 | $173.00M derived: 20-F 12 month − 6-K 9 month · filed 2016-02-11 | $233.00M 20-F · filed 2016-02-11 | $227.00M 20-F · filed 2014-02-10 | |
| 2013-09-30 | $60.00M 6-K · filed 2013-10-31 | |||
| 2012-12-31 | $233.00M 20-F · filed 2015-02-09 |